Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date. (HealthDay News) — For patients with diabetes, semaglutide use is ...

The hockey world received devastating news on April 8 as Chaz Lucius, a hockey prospect for the Manitoba Moose — the AHL affiliate of the NHL's Winnipeg Jets — announced his retirement at age 21 due ...

These muscles included the first lumbrical muscle (Lum1), second lumbrical muscle (Lum2), abductor pollicis brevis (APB), flexor pollicis brevis (FPB), first dorsal interosseous muscle (FDI), second ...

More information: Alan Y. Hsu et al, Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2025.0349 ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The Food and Drug Administration approved a medication this week known as VYKAT XR to treat hyperphagia — or an incessant feeling of hunger — in kids and adults with Prader-Willi syndrome. The ...

Disease name: Trimethylaminuria (TMAU), also known as "fish odor syndrome" Affected populations: TMAU is a rare metabolic condition that causes a person to smell like rotten fish. The condition is ...

March 27, 2025 – The FDA has approved a drug to treat a key symptom of a rare life-threatening genetic disorder known as Prader-Willi syndrome (PWS) in adults and children ages 4 or older.

The FDA has approved Soleno Therapeutics’ Vykat XR (diazoxide choline) extended-release tablets to treat hyperphagia in individuals aged four years and older with Prader-Willi syndrome (PWS). The ...